RNXT

RenovoRx, Inc. Common Stock
Data: 2026-01-30
$1.04
Price
6.77%
Change
$1.5
52W High
$0.701
52W Low

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Quick Stats
Jan 30, 2026

51.4

AI Score

HOLD

1.13

Volume Ratio

Apr 01, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

RNXT Stock Summary

Last updated Jan 30, 2026

RNXT is currently trading at $1.04, positioned below its 200-day moving average of $1.11, suggesting bearish momentum. The stock has a 52-week range of $0.701 to $1.5.

Technical Analysis: The 50-day moving average stands at $0.93, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 55.731, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.011, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RNXT at 51.4/100 with a HOLD recommendation.

RNXT (RenovoRx, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 55.731
CMF (20) 0.011
ROC (10) 0.971
ADX (14) 16.7
Indicator Value
MACD (12,26,9) 0.005
AROONOSC (14) -92.857
WILLAMS %R (14) -26.087
MFI (14) 36.709
RNXT Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

RNXT Price vs Max Options Open Interest
RNXT Max Change In Options Open Interest

RNXT Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RNXT Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RNXT Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

RNXT Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

RenovoRx, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

RNXT Moving Averages Analysis

RenovoRx, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026

RNXT (RenovoRx, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 0.98
20 1.01
30 0.97
50 0.93
100 1.04
200 1.11

RNXT Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 35.2 million
Earnings/Share ($) -0.36
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.315
EPS Estimate Next Year ($) -0.285
WallStreet Target Price ($) 5.5625
Most Recent Quarter